Resolving the Gap in Evidence on the Role of Warfarin in Venous Thromboembolism Management in Japan-Reference-Cited by-同舟云学术

Resolving the Gap in Evidence on the Role of Warfarin in Venous Thromboembolism Management in Japan

Published:2023-09-06 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Sugimura Koichiro¹

Affiliation:

1. Department of Cardiology, International University of Health and Welfare Narita Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-23-0582/_pdf

Reference12 articles.

1. 1. Japanese Circulation Society Joint Working Group. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2017) (in Japanese). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf (accessed July 17, 2023).

2. 2. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a firstepisode of venous thromboembolism. N Engl J Med 1995; 332: 1661–1665.

3. 3. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901–907.

4. 4. Yamada N, Hirayama A, Maeda H, Sakagami S, Shikata H, Prins MH, et al. Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism: The J-EINSTEIN DVT and PE program. Thromb J 2016; 13: 2, doi:10.1186/s12959-015-0035-3.

5. 5. Nakamura M, Nishikawa M, Komuro I, Kitajima I, Uetsuka Y, Yamagami T, et al. Apixaban for the treatment of Japanese subjects with acute venous thromboembolism (AMPLIFY-J study). Circ J 2015; 79: 1230–1236.